SCOPUS 정보 검색 플랫폼

JAMA - Journal of the American Medical Association

Volumn 323, Issue 19, 2020, Pages 1899-1900

Finding Effective Treatments for COVID-19: Scientific Integrity and Public Confidence in a Time of Crisis

(2) Goodman, Jesse L a Borio, Luciana b

a GEORGETOWN UNIVERSITY (United States)

b In Q Tel (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FAVIPIRAVIR; HYDROXYCHLOROQUINE; OSELTAMIVIR;

CLINICAL DECISION MAKING; CLINICAL STUDY; CORONAVIRUS DISEASE 2019; DRUG EFFICACY; DRUG SAFETY; EMERGENCY HEALTH SERVICE; GOOD CLINICAL PRACTICE; HEALTH CARE SYSTEM; HEALTH HAZARD; HUMAN; INFLUENZA A; INTENSIVE CARE; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; RISK BENEFIT ANALYSIS; TRUST; BETACORONAVIRUS; COMPASSIONATE USE; CORONAVIRUS INFECTION; OFF LABEL DRUG USE; PANDEMIC; RANDOMIZED CONTROLLED TRIAL (TOPIC); VIRUS PNEUMONIA;

BETACORONAVIRUS; COMPASSIONATE USE TRIALS; CORONAVIRUS INFECTIONS; HUMANS; OFF-LABEL USE; PANDEMICS; PNEUMONIA, VIRAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85083707515 PISSN: 00987484 EISSN: 15383598 Source Type: Journal
DOI: 10.1001/jama.2020.6434 Document Type: Note

Times cited : (50)

References (10)

1
- 85082537970
- Treating COVID-19 - Off-label drug use, compassionate use, and randomized clinical trials during pandemics
- Published online March 24, doi: 32208486
- Kalil AC. Treating COVID-19-off-label drug use, compassionate use, and randomized clinical trials during pandemics. JAMA. Published online March 24, 2020. doi: 10.1001/jama.2020.4742 32208486
- (2020) JAMA
- Kalil, A.C.¹

2
- 85083387934
- US Food and Drug Administration. Published March 28, 2020. Accessed April 13, 2020.
- US Food and Drug Administration. Request for emergency use authorization for use of chloroquine phosphate or hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of 2019 coronavirus disease. Published March 28, 2020. Accessed April 13, 2020. https://www.fda.gov/media/136534/download
- Request for Emergency Use Authorization for Use of Chloroquine Phosphate or Hydroxychloroquine Sulfate Supplied from the Strategic National Stockpile for Treatment of 2019 Coronavirus Disease

3
- 84907403863
- Studying "secret serums" - Toward safe, effective Ebola treatments
- doi: 25140857
- Goodman JL. Studying "secret serums"-toward safe, effective Ebola treatments. N Engl J Med. 2014; 371 (12): 1086-1089. doi: 10.1056/NEJMp1409817 25140857
- (2014) N Engl J Med , vol.371 , Issue.12 , pp. 1086-1089
- Goodman, J.L.¹

4
- 85047848790
- Ethics of randomized trials in a public health emergency
- e0006313. doi: 29771907
- London AJ, Omotade OO, Mello MM, Keusch GT. Ethics of randomized trials in a public health emergency. PLoS Negl Trop Dis. 2018; 12 (5): e0006313. doi: 10.1371/journal.pntd.0006313 29771907
- (2018) PLoS Negl Trop Dis , vol.12 , Issue.5
- London, A.J.¹ Omotade, O.O.² Mello, M.M.³ Keusch, G.T.⁴

5
- 85080972220
- Of chloroquine and COVID-19
- 104762. doi: 32147496
- Touret F, de Lamballerie X. Of chloroquine and COVID-19. Antiviral Res. 2020; 177: 104762. doi: 10.1016/j.antiviral.2020.104762 32147496
- (2020) Antiviral Res , vol.177
- Touret, F.¹ De Lamballerie, X.²

6
- 85085231870
- US Department of Health and Human Services. . Published January 2017. Accessed April 13, 2020.
- US Department of Health and Human Services. Emergency use authorization of medical products and related authorities. Published January 2017. Accessed April 13, 2020. https://www.fda.gov/media/97321/download
- Emergency Use Authorization of Medical Products and Related Authorities

7
- 85082769897
- hiteHouse.gov. April 6, Accessed April 13, 2020.
- Remarks by President Trump, Vice President Pence, and members of the coronavirus task force in press briefing. WhiteHouse.gov. April 6, 2020. Accessed April 13, 2020. https://www.whitehouse.gov/briefings-statements/remarks-president-trump-vice-president-pence-members-coronavirus-task-force-press-briefing-20/
- (2020) Remarks by President Trump, Vice President Pence, and Members of the Coronavirus Task Force in Press Briefing

8
- 85085231564
- White House pressures FDA on unproven Japanese drug. Politico. March 31, 2020. Accessed April 13, 2020.
- Diamond D, Toosi N. White House pressures FDA on unproven Japanese drug. Politico. March 31, 2020. Accessed April 13, 2020. https://www.politico.com/news/2020/03/31/white-house-pressures-fda-japanese-drug-157587
- Diamond, D.¹ Toosi, N.²

9
- 85085231772
- STAT. March 31, 2020. Accessed April 13, 2020.
- Fuerstein A. Rudy Giuliani wants FDA to fast-track a stem cell therapy for Covid-19; critics see political meddling. STAT. March 31, 2020. Accessed April 13, 2020. https://www.statnews.com/2020/03/31/rudy-giuliani-wants-fda-to-fast-track-a-stem-cell-therapy-for-covid-19-critics-see-political-meddling/
- Rudy Giuliani Wants FDA to Fast-track A Stem Cell Therapy for Covid-19; Critics See Political Meddling
- Fuerstein, A.¹

10
- 85080921550
- Clinical trial analysis of 2019-nCoV therapy registered in China
- Published online February 18, doi: 32108352
- Zhang Q, Wang Y, Qi C, Shen L, Li J. Clinical trial analysis of 2019-nCoV therapy registered in China. J Med Virol. Published online February 18, 2020. doi: 10.1002/jmv.25733 32108352
- (2020) J Med Virol
- Zhang, Q.¹ Wang, Y.² Qi, C.³ Shen, L.⁴ Li, J.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.